Matt has advised clients developing and commercializing oncology therapeutics for indications ranging in size from fewer than 100 patients per year to greater than 250,000 patients per year.

Matt is an associate principal in ZS’s Philadelphia office and a member of the ZS oncology vertical leadership team. He supports and leads ZS's oncology engagements in marketing strategy, market research, forecasting and secondary data analytics.

Matt’s expertise spans solid tumors and hematological malignancies, with a special interest in rare and difficult-to-treat tumor types. Matt has attended ASCO and ASH on behalf of the ZS oncology vertical for five consecutive years. Matt also has expertise in advising his clients on the development and commercialization of novel oncology therapeutics.

Prior to focusing exclusively on oncology, Matt worked in data analytics and forecasting across therapeutic areas (including oncology). Before ZS, Matt worked with a boutique healthcare consulting firm, focused primarily in the CV and oncology spaces. Prior to consulting, he studied the influence of diet on the biophysics of neutrophil cell membranes.

Matt holds a Ph.D. in bioengineering from the University of Pennsylvania. He also holds a bachelor of science degree in biomedical engineering from Duke University.